Correspondence 0001104659-22-121322 from CXApp Inc. (CXAI)
CXApp Inc.
Date: Nov. 22, 2022 · CIK: 0001820875 · Accession: 0001104659-22-121322
AI Filing Summary & Sentiment
File numbers found in text: 001-39642
Referenced dates: November 17, 2022
Show Raw Text
CORRESP
1
filename1.htm
DIRECT DIAL
650-470-3130
DIRECT FAX
650-798-6510
EMAIL ADDRESS
MICHAEL.MIES@SKADDEN.COM
Skadden,
Arps, Slate, Meagher & Flom llp
525 University
Avenue
Palo Alto,
California 94301
-----------
TEL: (650) 470-4500
FAX: (650) 470-4570
www.skadden.com
November 22, 2022
FIRM/AFFILIATE OFFICES
-----------
BOSTON
CHICAGO
HOUSTON
LOS ANGELES
NEW YORK
WASHINGTON, D.C.
WILMINGTON
-----------
BEIJING
BRUSSELS
FRANKFURT
HONG KONG
LONDON
MUNICH
PARIS
SÃO PAULO
SEOUL
SHANGHAI
SINGAPORE
TOKYO
TORONTO
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Edwin Kim
Joshua Shainess
Division of Corporation Finance
Office of Technology
Re: KINS Technology Group, Inc.
Preliminary Proxy Statement on Schedule
14A
Filed November 8, 2022
File No. 001-39642
Ladies and Gentlemen:
This letter sets forth the
response of KINS Technology Group, Inc. (the “Company”) to the comment of the staff of the Division of
Corporation Finance (the “Staff”) of the U.S. Securities and Exchange Commission set forth in your letter dated
November 17, 2022, with respect to the above referenced Preliminary Proxy Statement on Schedule 14A (the “Proxy Statement”).
The text of the Staff’s
comment has been included in this letter for your convenience. We have also set forth the Company’s response immediately below the
text of the comment. Unless otherwise indicated, capitalized terms used herein have the meanings assigned to them in the Proxy Statement.
U.S. Securities and Exchange Commission
Division of Corporation Finance
November 22, 2022
Page 2
Preliminary Proxy Statement on Schedule
14A filed November 8, 2022
1. Staff’s Comment:
With a view toward disclosure, please tell us whether your sponsor is, is controlled by, has substantial ties with a non-U.S.
person. If so, also include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business
combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a U.S.
target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in
the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete
an initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or
a decision to prohibit the transaction could prevent you from completing an initial business combination and require you to liquidate.
Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price
appreciation in the combined company, and the warrants, which would expire worthless.
Response:
The Company’s sponsor is a Delaware limited liability company and is not controlled by, and does not have substantial ties with,
any non-U.S. person or entity. Accordingly, the Company does not intend to make any additional disclosures in future filings.
2. Staff’s Comment: Given that the vast majority of Class A stockholders have already
redeemed their shares, please disclose prominently, if true, that as a result of such redemptions and the existence of the Support Agreements,
Class B stockholders have a sufficient percentage of votes to approve both the business combination and the request for an extension
of the life of the SPAC pertaining to the proposals within this proxy statement.
Response:
The Company acknowledges the Staff’s comment and intends to include in the definitive proxy statement the following disclosure in
the stockholder letter, and on page 5, page 13, page 27, page 31 and page 32 in the paragraphs relating to the
required vote:
“The Sponsor, in its capacity
as a KINS stockholder, intends to vote the KINS Founder Shares owned by it in favor of each of the proposals. On June 10, 2022, in
connection with the Company’s previous extension, 26,661,910 shares of Class A Common Stock (representing approximately 96.6%
of the then outstanding Class A Common Stock) were tendered for redemption and redeemed, resulting in 938,080 shares of Class A
Common Stock remaining. As a result, Sponsor’s 6,150,000 Founder Shares now represent approximately 78.46% of the total voting power
of the Company. Accordingly, it is expected that the shares of KINS Common Stock held by Sponsor will be sufficient to establish quorum
and to pass each of the Amendment Proposal, the Trust Extension Proposal and the Adjournment Proposal.”
U.S. Securities and Exchange Commission
Division of Corporation Finance
November 22, 2022
Page 3
Please contact me at (650) 470-3130
should you require further information.
Very truly yours,
/s/ Michael Mies
cc: Khurram P. Sheikh, CEO KINS Technology Group, Inc.